Home »
(HealthDay)—Using buprenorphine to treat opioid use disorder (OUD) may increase adherence to treatments for other chronic conditions, according to a study published in the September issue of Medical Care. Hsien-Yen Chang, Ph.D., from Johns Hopkins University in Baltimore, and colleagues used Truven Health’s MarketScan data to identify 12,719 commercially insured individuals with a diagnosis of […]
The maker of the powerful painkiller OxyContin has agreed to provide access to propriety research and other data to researchers at Oklahoma State University to help them find causes and treatments for drug addiction. Stamford, Connecticut-based Purdue Pharma announced the agreement Thursday in a joint statement with the university. Purdue said it will provide Oklahoma […]
Two Ebola patients who were treated with new drugs in the city of Goma in eastern Congo have been declared “cured” and returned to their home. Top doctors fighting Ebola quickly used the case on Tuesday to press the message that people can recover from the potentially deadly disease if they seek proper care. Ebola […]
(HealthDay)—Benzodiazepines and muscle relaxants are associated with serious falls among people living with HIV in their 50s, according to a study recently published in the Journal of Acquired Immune Deficiency Syndrome. Julie A. Womack, Ph.D., from the VA Connecticut Healthcare System in West New Haven, and colleagues investigated whether the association between polypharmacy, hazardous alcohol […]
(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, according to a study published online July 9 in Hematology/Oncology and Stem Cell Therapy. Ana Jiménez-Ubieto, M.D., Ph.D., from the Hospital Universitario 12 de Octubre in Madrid, and colleagues […]
A first-in-class drug recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) for adult patients with heavily pretreated multiple myeloma has been the subject of study at Moffitt Cancer Center for years. Now, selinexor (XPOVIO, Karyopharm Therapeutics) used in combination with the corticosteroid dexamethasone will offer another option for patients with multiple […]
Ayao* is a tall and well-built 15-year-old, and like many his age, he is very particular about his appearance. He wears a white T-shirt with a colourful design on the front, white trousers and Kappa slip-on sandals. He likes to put a lot of effort into grooming his stylishly cut hair. When I meet him […]
Adverse drug events could be avoided by sharing patients’ medication histories and previous harmful medication exposures among various health-care facilities. That’s one of the key findings of a study published today in CMAJ Open. Led by Vancouver Coastal Health Research Institute and UBC researcher Dr. Corinne Hohl, the study’s conclusions are a wake-up call to […]
When Kent Hutchison’s 70-year-old mother traveled to Colorado in 2014 to explore using marijuana to ease her chronic pain, she got different—often contradictory—advice from every dispensary she visited. Two years later, when his partner Angela Bryan asked her doctors about using cannabis to quell the side-effects from her breast cancer treatments, she was met with […]
A new study has shown how cannabis could be an effective treatment option for both pain relief and insomnia, for those looking to avoid prescription and over the counter pain and sleep medications—including opioids. The study, published in the Journal of Psychoactive Drugs, which looked at 1,000 people taking legalized marijuana in an American state […]